Allergan Gets Lexapro Teen Suicide Suit Thrown Out

Allergan, Inc. won dismissal of a family’s suit linking the antidepressant Lexapro to their teenage daughter’s suicide.

The family alleged Allergan and unit Forest Laboratories, Inc. didn’t give a strong enough warning about the risk of suicide in children and adolescents taking Lexapro.

The defendants’ marketing campaign misled the Food and Drug Administration, doctors, and the public about suicide-related risks associated with Lexapro use in pediatric and adolescent population, the plaintiffs said.

But the U.S. District Court for the Central District of California dismissed the family’s complaint for the third time Sept. 19 and said they can’t try again.

The ...